Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1994-2-7
|
pubmed:abstractText |
Besides rheumatoid factor (RF), antikeratin antibodies (AKA) and antiperinuclear factor (APN), anti-RA 33 antibody has been described as a highly specific antinuclear antibody for rheumatoid arthritis (RA). In this study RA 33 antibodies were detected using Western blotting with HeLa cell nuclear extract in a group of 94 RA patients and 259 controls. Anti-RA 33 was present in 35% of 94 RA patients, with a similar frequency in RF positive (32%) and RF-negative (45%) RA patients. RA-33 antibody was also present in 60% of a group of 30 patients with anti-U1 RNP positive mixed connective tissue disease. The specificity of anti-RA 33 for RA was 84.6%. Anti-RA 33 antibody was already present in sera from 23.5% of 18 patients with RA of less than one year's duration. Anti-RA 33 antibody was the only positive immunological marker in 3/20 cases of seronegative adult RA. No correlations were found between anti-RA 33 antibody and AKA or APF. Patients with erosive RA and patients whose ESR was > or = 50 mm after 1 hour were more likely to be anti-RA 33 positive (47.6% vs 24.4% and 42.8% vs 29.4%). These results suggest that anti-RA 33 antibody, in the absence of anti-U1-RNP antibodies, can be added to the list of the helpful serological markers for rheumatoid arthritis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Antineutrophil...,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Antinuclear,
http://linkedlifedata.com/resource/pubmed/chemical/Autoantibodies,
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/Keratins
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0392-856X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
11
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
473-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7506130-Adult,
pubmed-meshheading:7506130-Aged,
pubmed-meshheading:7506130-Aged, 80 and over,
pubmed-meshheading:7506130-Antibodies, Antineutrophil Cytoplasmic,
pubmed-meshheading:7506130-Antibodies, Antinuclear,
pubmed-meshheading:7506130-Arthritis, Rheumatoid,
pubmed-meshheading:7506130-Autoantibodies,
pubmed-meshheading:7506130-Biological Markers,
pubmed-meshheading:7506130-Diagnosis, Differential,
pubmed-meshheading:7506130-Female,
pubmed-meshheading:7506130-Humans,
pubmed-meshheading:7506130-Keratins,
pubmed-meshheading:7506130-Male,
pubmed-meshheading:7506130-Middle Aged,
pubmed-meshheading:7506130-Mixed Connective Tissue Disease,
pubmed-meshheading:7506130-Sensitivity and Specificity
|
pubmed:articleTitle |
Anti-RA 33 antinuclear autoantibody in rheumatoid arthritis and mixed connective tissue disease: comparison with antikeratin and antiperinuclear antibodies.
|
pubmed:affiliation |
Clinique de Rhumatologie, Université Paris, Hôpital Bichat, France.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|